NEW ORLEANS, Oct. 21, 2016 -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 19, 2016 to file lead plaintiff applications in a securities class action lawsuit against Pilgrim’s Pride Corporation (Nasdaq:PPC), if they purchased the Company’s securities between February 21, 2014 and October 6, 2016, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Colorado.
What You May Do
If you purchased shares of Pilgrim’s Pride and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by December 19, 2016.
About the Lawsuit
Pilgrim’s Pride and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On September 2, 2016, a food distributor filed an antitrust class action complaint against Pilgrim’s Pride and several other poultry producers, including Tyson Foods, Inc. (“Tyson”), alleging that the defendants had conspired since 2008 to manipulate the prices of broiler chicken in violation of antitrust laws. Seven more antitrust complaints were filed between September 7 and October 7.
Then, on October 7, 2016, Pivotal Research downgraded Tyson from “Hold” to “Sell,” stating that the allegations of the antitrust complaints were “powerfully convincing.”
On this news, the price of Pilgrim’s Pride’s shares plummeted.
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact: Kahn Swick & Foti, LLC Lewis Kahn, Managing Partner [email protected] 1-877-515-1850 206 Covington St. Madisonville, LA 70447


FDA Approves Mitapivat for Anemia in Thalassemia Patients
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



